281 related articles for article (PubMed ID: 24778394)
1. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
2. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
6. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
[TBL] [Abstract][Full Text] [Related]
8. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
9. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
[TBL] [Abstract][Full Text] [Related]
10. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
11. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
[TBL] [Abstract][Full Text] [Related]
12. Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis.
Ngeow J; Liu C; Zhou K; Frick KD; Matchar DB; Eng C
J Clin Oncol; 2015 Aug; 33(23):2537-44. PubMed ID: 26169622
[TBL] [Abstract][Full Text] [Related]
13. Novel Germline
Lopez C; Abuel-Haija M; Pena L; Coppola D
Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
[TBL] [Abstract][Full Text] [Related]
14. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
[TBL] [Abstract][Full Text] [Related]
15. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
[TBL] [Abstract][Full Text] [Related]
16. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
Ngeow J; Eng C
Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
[TBL] [Abstract][Full Text] [Related]
17. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract][Full Text] [Related]
19. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
20. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
